Rivaara Labs raises its first round of equity capital from Amicus, Kotak | The Financial Express

Rivaara Labs raises its first round of equity capital from Amicus, Kotak

Bharat Daftary, who founded the company in 2019, also participated in the round.

Rivaara Labs raises its first round of equity capital from Amicus, Kotak
According to industry sources, the fundraising has been to the tune of Rs 50-60 crore. (Photo for representational purpose only/ Pixabay)

Rivaara Labs, a testing services and R&D-focused molecular diagnostics company, raised its first institutional round of equity led by Amicus Capital and Kotak Investment Advisors. Bharat Daftary, who founded the company in 2019, also participated in the round. According to industry sources, the fundraising has been to the tune of Rs 50-60 crore.

Rivaara has developed PCR-based test kits, specifically for detecting pathogens prevalent in India, in collaboration with European research labs.

Also Read: Indian startups raise over $995 million VC funding in August 

Daftary said, “The vision for Rivaara is to positively impact patient care by addressing gaps in widespread adoption of molecular diagnostics… Amicus and Kotak have an in-depth understanding of the healthcare sector and are aligned with our vision…”

Also Read: VIL board to consider up to Rs 500 cr fundraising from Voda Group

Sunil Theckath Vasudevan, co-founder and partner, Amicus Capital, said, “We are very excited to partner with Rivaara’s journey to bring faster and accurate diagnostics to India.” Dhiraj Rajendran, ED, Kotak Investment Advisors, said, “Advances in molecular diagnostics over the last few years have opened up possibilities for faster and accurate ways to detect pathogens at an affordable price. Adoption of these advances like RT-PCR tests was seen during the pandemic period.

Get live Share Market updates and latest India News and business news on Financial Express. Download Financial Express App for latest business news.

First published on: 09-11-2022 at 03:30 IST